Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02505165 · ClinicalTrials.gov registry record · NA
Illness Management and Parental Adjustment to Cancer Treatment
A NA study of Lymphoma and Leukemia, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 279
- Enrollment target
- 3
- Study locations
NCT02505165: Completed NA study of Lymphoma and Leukemia, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02505165 is a NA study of Lymphoma and Leukemia that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 279 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (42% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02505165, a NA study of Lymphoma and Leukemia, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 279 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to test the efficacy of a clinic-based intervention designed to reduce illness uncertainty for parents of children who have been recently diagnosed with cancer.
Primary Outcome
indicator of global psychological symptoms
Conditions Studied
Interventions
- BEHAVIORAL IMPACT
- OTHER ESO
Study Locations (3)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Dayton Children's Hospital - Dayton
Oklahoma
- University of Oklahoma Health Sciences Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2015-11-19 |
| Est. Completion | 2022-02-01 |
| Phase | NA |
What the finished NCT02505165 record still lists
NCT02505165 is an interventional study that assigns participants to a tested intervention. The registered 279 participants enrollment target is mid-sized for trials with a published cap, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (42% lower).
The record links to 4 conditions, with Lymphoma appearing as the primary indexed condition, and to 2 interventions - of which IMPACT is the first listed.
NCT02505165 reports a single indexed study location in Ohio, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT02505165 about?
NCT02505165 is a clinical study titled "Illness Management and Parental Adjustment to Cancer Treatment". The purpose of this study is to test the efficacy of a clinic-based intervention designed to reduce illness uncertainty for parents of children who have been recently diagnosed with cancer.
What is the current status of trial NCT02505165?
This trial is currently completed. It is a NA study. The enrollment target is 279 participants. The study started on 2015-11-19. Estimated completion is 2022-02-01.
What conditions does trial NCT02505165 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Solid Tumor, Brain Tumor.
What interventions are being tested in trial NCT02505165?
The interventions under investigation include: IMPACT (BEHAVIORAL), ESO (OTHER).
Who is sponsoring clinical trial NCT02505165?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02505165 being conducted?
This trial has 3 study locations across Ohio, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02505165's enrollment target sits among peer trials
279 36th of 299 higher than 264 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04783857 · 279 participants · Phase 4
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
- NCT05407324 · 279 participants · Phase 2
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- NCT06299748 · 279 participants
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- NCT06582784 · 279 participants · NA
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI